STOCK TITAN

Hinge Health chairman sells 200,000 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Hinge Health, Inc. director, executive chairman and co-founder Gabriel M.I. Mecklenburg converted 200,000 Class B shares into 200,000 Class A shares on November 11, 2026, then sold 200,000 Class A shares in five reported transactions. The sales were made under a Rule 10b5-1 trading plan adopted June 12, 2026.

The conversion row reports 1,444,004 directly held Class B shares following that transaction. Separate indirect Class B holdings were 383,592 shares through a Family Trust and 692,710 through a GRAT; each Class B share is convertible into one Class A share.

Insider Mecklenburg Gabriel M.I.
Role Director
Sold 200,000 shs ($24.48M)
Approx. gross sale proceeds $24.48M
Type Security Shares Price Value
Conversion Class B Common Stock F7 200,000 $0.00 $0.00
Conversion Class A Common Stock 200,000 $0.00 $0.00
Sale Class A Common Stock F1, F2 104,525 $121.7581 $12.73M
Sale Class A Common Stock F1, F3 67,873 $122.7327 $8.33M
Sale Class A Common Stock F1, F4 16,615 $123.5394 $2.05M
Sale Class A Common Stock F1, F5 8,607 $124.7575 $1.07M
Sale Class A Common Stock F1, F6 2,380 $125.5041 $299K
Holding Class B Common Stock F7 -- -- --
Holding Class B Common Stock F7 -- -- --
Holdings After Transaction: Class B Common Stock — 1,444,004 shares (Direct); Class A Common Stock — 0 shares (Direct); Class B Common Stock — 383,592 shares (Indirect, By Family Trust); Class B Common Stock — 692,710 shares (Indirect, By GRAT)
Footnotes (7)
  1. F1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026.
  2. F2. Represents the weighted average sale price. The lowest price at which shares were sold was $121.28 and the highest price at which shares were sold was $122.27. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
  3. F3. Represents the weighted average sale price. The lowest price at which shares were sold was $122.28 and the highest price at which shares were sold was $123.27. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
  4. F4. Represents the weighted average sale price. The lowest price at which shares were sold was $123.28 and the highest price at which shares were sold was $124.24. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
  5. F5. Represents the weighted average sale price. The lowest price at which shares were sold was $124.28 and the highest price at which shares were sold was $125.26. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
  6. F6. Represents the weighted average sale price. The lowest price at which shares were sold was $125.35 and the highest price at which shares were sold was $125.57. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
  7. F7. Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
Class A shares sold; weighted average price 104,525 shares at $121.7581 per share November 11, 2026 sale
Class A shares sold; weighted average price 67,873 shares at $122.7327 per share November 11, 2026 sale
Class A shares sold; weighted average price 16,615 shares at $123.5394 per share November 11, 2026 sale
Class A shares sold; weighted average price 8,607 shares at $124.7575 per share November 11, 2026 sale
Class A shares sold; weighted average price 2,380 shares at $125.5041 per share November 11, 2026 sale
Class B-to-Class A conversion 200,000 shares converted November 11, 2026
Direct Class B shares following conversion 1,444,004 shares Reported following the conversion on November 11, 2026
Indirect Class B holdings 383,592 shares held by Family Trust; 692,710 shares held by GRAT Reported November 11, 2026; convertible into Class A shares
Rule 10b5-1 trading plan regulatory
"sales were effected pursuant to a Rule 10b5-1 trading plan"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"Represents the weighted average sale price"
Class B Common Stock technical
"Each share of Class B Common Stock is convertible"
A class B common stock is one of multiple types of a company’s ordinary shares that carries specific rights—often different voting power or dividend priority—compared with other classes. For investors it matters because those differences affect how much influence you have over company decisions, the income you might receive, and how freely the shares trade; think of it like owning a car with different keys: some keys let you start the engine and open the trunk, others only unlock the door.
GRAT technical
"By GRAT"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HNGE shares did Gabriel M.I. Mecklenburg sell, and at what prices?

Mecklenburg sold 200,000 Class A shares on November 11, 2026, across five reported transactions: 104,525 at a weighted average $121.7581 per share; 67,873 at $122.7327; 16,615 at $123.5394; 8,607 at $124.7575; and 2,380 at $125.5041. The sales were made under a Rule 10b5-1 trading plan adopted June 12, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Mecklenburg Gabriel M.I.

(Last)(First)(Middle)
C/O HINGE HEALTH, INC.
455 MARKET STREET, SUITE 700

(Street)
SAN FRANCISCO CALIFORNIA 94105

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
Officer (give title below)XOther (specify below)
Exec. Chairman & Co-Founder
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/11/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock11/11/2026C200,000A$0200,000D
Class A Common Stock11/11/2026S(1)104,525D$121.7581(2)95,475D
Class A Common Stock11/11/2026S(1)67,873D$122.7327(3)27,602D
Class A Common Stock11/11/2026S(1)16,615D$123.5394(4)10,987D
Class A Common Stock11/11/2026S(1)8,607D$124.7575(5)2,380D
Class A Common Stock11/11/2026S(1)2,380D$125.5041(6)0D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Class B Common Stock(7)11/11/2026C200,000 (7) (7)Class A Common Stock200,000$01,444,004D
Class B Common Stock(7) (7) (7)Class A Common Stock383,592383,592IBy Family Trust
Class B Common Stock(7) (7) (7)Class A Common Stock692,710692,710IBy GRAT
Explanation of Responses:
1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 12, 2026.
2. Represents the weighted average sale price. The lowest price at which shares were sold was $121.28 and the highest price at which shares were sold was $122.27. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
3. Represents the weighted average sale price. The lowest price at which shares were sold was $122.28 and the highest price at which shares were sold was $123.27. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
4. Represents the weighted average sale price. The lowest price at which shares were sold was $123.28 and the highest price at which shares were sold was $124.24. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
5. Represents the weighted average sale price. The lowest price at which shares were sold was $124.28 and the highest price at which shares were sold was $125.26. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
6. Represents the weighted average sale price. The lowest price at which shares were sold was $125.35 and the highest price at which shares were sold was $125.57. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
7. Each share of Class B Common Stock is convertible into one share of the lssuer's Class A Common Stock at any time, at the election of the holder or automatically upon certain transfers, whether or not for value, or upon the occurrence of certain events or conditions described in the Issuer's Amended and Restated Certificate of Incorporation.
/s/ James Budge, Attorney-in-Fact11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading